Silexion Therapeutics - Warrants(14/08/2029) Current Cash

The latest current cash for SLXNW is $2.2M as of June 2026. That compares with $3.5M in the prior-year period — down 35.7% year over year. Investors often review this figure alongside Silexion Therapeutics - Warrants(14/08/2029)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SLXNW's current cash moved from $3.5M to $2.2M — a 35.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Silexion Therapeutics - Warrants(14/08/2029)'s operating scale or balance-sheet position.

A current cash figure of $2.2M for SLXNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SLXNW's current cash ($2.2M), review year-over-year change from $3.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.